Cargando…

Clinical and Molecular Analysis of Four Patients With 11β-Hydroxylase Deficiency

Objective: 11β-hydroxylase deficiency (11βOHD) is a rare autosomal recessive disorder caused by mutations in the CYP11B1 gene. It is characterized by virilization, hypertension, and significant final height impairment. In this study, we aim to investigate the clinical and molecular characteristics o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qiaoli, Wang, Dandan, Wang, Chunli, Zheng, Bixia, Liu, Qianqi, Zhu, Ziyang, Jia, Zhanjun, Gu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396487/
https://www.ncbi.nlm.nih.gov/pubmed/32850530
http://dx.doi.org/10.3389/fped.2020.00410
_version_ 1783565592896208896
author Zhou, Qiaoli
Wang, Dandan
Wang, Chunli
Zheng, Bixia
Liu, Qianqi
Zhu, Ziyang
Jia, Zhanjun
Gu, Wei
author_facet Zhou, Qiaoli
Wang, Dandan
Wang, Chunli
Zheng, Bixia
Liu, Qianqi
Zhu, Ziyang
Jia, Zhanjun
Gu, Wei
author_sort Zhou, Qiaoli
collection PubMed
description Objective: 11β-hydroxylase deficiency (11βOHD) is a rare autosomal recessive disorder caused by mutations in the CYP11B1 gene. It is characterized by virilization, hypertension, and significant final height impairment. In this study, we aim to investigate the clinical and molecular characteristics of four unrelated Chinese patients with 11βOHD disorder. Methods: The clinical information of four 11βOHD patients were carefully reviewed. Genetic analysis was performed using next-generation sequencing (NGS) based panel analysis. NGS coverage depth was analyzed to detect exonic copy-number variants (CNVs) on patient 1. Quantitative PCR (qPCR) was subsequently performed to confirm the CNVs detected from the NGS coverage depth analysis. Results: The mean age of the patients at diagnosis was 4.7 years (range, 2.0–9.3 years). Two genetically female patients (patients 1 and 2) with 11βOHD presented severe virilization of external genitalia and were raised as males. Two genetically male patients (patients 3 and 4) presented precocious puberty. Additionally, patients 1, 3, and 4 presented with hypertension. In patient 4, unilateral adrenal mass was detected and removed at the age of 9 years. Interestingly, the height of patient 4 (174.4 cm, +6.7 SD) wasn't impaired and reached his mid-parental height (173 cm). Three novel variants in the CYP11B1 gene (c.1150_1153del, c.217C>T, and c.400G>C) were identified by NGS. Various bioinformatics tools revealed potential pathogenic effects for the novel variants, and evolutionary-conservation revealed that the novel missense variant affected an amino acid that is highly conserved among species. Furthermore, NGS coverage depth analysis and qPCR identified a novel heterozygous deletion of exons 1–6 in patient 1. Conclusion: Our study expands the spectrum of mutations of the CYP11B1 gene in Chinese population. In addition, We reported the first case of a patient with classical 11βOHD disorder, whose final height wasn't compromised.
format Online
Article
Text
id pubmed-7396487
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73964872020-08-25 Clinical and Molecular Analysis of Four Patients With 11β-Hydroxylase Deficiency Zhou, Qiaoli Wang, Dandan Wang, Chunli Zheng, Bixia Liu, Qianqi Zhu, Ziyang Jia, Zhanjun Gu, Wei Front Pediatr Pediatrics Objective: 11β-hydroxylase deficiency (11βOHD) is a rare autosomal recessive disorder caused by mutations in the CYP11B1 gene. It is characterized by virilization, hypertension, and significant final height impairment. In this study, we aim to investigate the clinical and molecular characteristics of four unrelated Chinese patients with 11βOHD disorder. Methods: The clinical information of four 11βOHD patients were carefully reviewed. Genetic analysis was performed using next-generation sequencing (NGS) based panel analysis. NGS coverage depth was analyzed to detect exonic copy-number variants (CNVs) on patient 1. Quantitative PCR (qPCR) was subsequently performed to confirm the CNVs detected from the NGS coverage depth analysis. Results: The mean age of the patients at diagnosis was 4.7 years (range, 2.0–9.3 years). Two genetically female patients (patients 1 and 2) with 11βOHD presented severe virilization of external genitalia and were raised as males. Two genetically male patients (patients 3 and 4) presented precocious puberty. Additionally, patients 1, 3, and 4 presented with hypertension. In patient 4, unilateral adrenal mass was detected and removed at the age of 9 years. Interestingly, the height of patient 4 (174.4 cm, +6.7 SD) wasn't impaired and reached his mid-parental height (173 cm). Three novel variants in the CYP11B1 gene (c.1150_1153del, c.217C>T, and c.400G>C) were identified by NGS. Various bioinformatics tools revealed potential pathogenic effects for the novel variants, and evolutionary-conservation revealed that the novel missense variant affected an amino acid that is highly conserved among species. Furthermore, NGS coverage depth analysis and qPCR identified a novel heterozygous deletion of exons 1–6 in patient 1. Conclusion: Our study expands the spectrum of mutations of the CYP11B1 gene in Chinese population. In addition, We reported the first case of a patient with classical 11βOHD disorder, whose final height wasn't compromised. Frontiers Media S.A. 2020-07-24 /pmc/articles/PMC7396487/ /pubmed/32850530 http://dx.doi.org/10.3389/fped.2020.00410 Text en Copyright © 2020 Zhou, Wang, Wang, Zheng, Liu, Zhu, Jia and Gu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Zhou, Qiaoli
Wang, Dandan
Wang, Chunli
Zheng, Bixia
Liu, Qianqi
Zhu, Ziyang
Jia, Zhanjun
Gu, Wei
Clinical and Molecular Analysis of Four Patients With 11β-Hydroxylase Deficiency
title Clinical and Molecular Analysis of Four Patients With 11β-Hydroxylase Deficiency
title_full Clinical and Molecular Analysis of Four Patients With 11β-Hydroxylase Deficiency
title_fullStr Clinical and Molecular Analysis of Four Patients With 11β-Hydroxylase Deficiency
title_full_unstemmed Clinical and Molecular Analysis of Four Patients With 11β-Hydroxylase Deficiency
title_short Clinical and Molecular Analysis of Four Patients With 11β-Hydroxylase Deficiency
title_sort clinical and molecular analysis of four patients with 11β-hydroxylase deficiency
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396487/
https://www.ncbi.nlm.nih.gov/pubmed/32850530
http://dx.doi.org/10.3389/fped.2020.00410
work_keys_str_mv AT zhouqiaoli clinicalandmolecularanalysisoffourpatientswith11bhydroxylasedeficiency
AT wangdandan clinicalandmolecularanalysisoffourpatientswith11bhydroxylasedeficiency
AT wangchunli clinicalandmolecularanalysisoffourpatientswith11bhydroxylasedeficiency
AT zhengbixia clinicalandmolecularanalysisoffourpatientswith11bhydroxylasedeficiency
AT liuqianqi clinicalandmolecularanalysisoffourpatientswith11bhydroxylasedeficiency
AT zhuziyang clinicalandmolecularanalysisoffourpatientswith11bhydroxylasedeficiency
AT jiazhanjun clinicalandmolecularanalysisoffourpatientswith11bhydroxylasedeficiency
AT guwei clinicalandmolecularanalysisoffourpatientswith11bhydroxylasedeficiency